Group items tagged

Roberts and Tren's key argument is that reductions in malaria in the Americas were not the result of http://www.thegef.org/gef/">Global Environmental Facility interventions but were caused by increased use of antimalarial drugs. In their own words: "However, their successes were not a result of the interventions we describe as components of the GEF project. Their successes were mostly a result of wide distributions of antimalarial drugs to suppress malaria (see Table 1). Data in the Table reveal trends of increased numbers of antimalarial pills distributed per diagnosed case and decreased numbers of cases. Equally obvious is the decreased numbers of pills distributed per diagnosed case, and increased numbers of cases in two countries (Costa Rica and Panama)." Bogus Windows Firewall and Security Center Update Email Links To Malware Outline Email purporting to be from Microsoft Canada instructs recipients to click a link in order to download and install a high priority security update for the Microsoft Windows Firewall and Security Center. Brief Analysis The email is not from Microsoft and the link does not point to a security update. Instead, following the instructions in the message will download and install malware. Microsoft will never send security updates via an email.  The Acts of an Oedipus: Power, Language, and Sacrifice in Ralph Ellison's Invisible Man In our analysis, the rhetoric of mastery is derivative of the primary form of rhetoric, which emerges from the periphery as a denunciation of those who usurp the center: the outsider, or the collectivity of outsiders, undermines the position of the insider. By the basic geometry of the center-periphery opposition, rhetoric is a "majoritary" phenomenon; the peripheral denouncers are more numerous than their central targets. But the essential features of the circle are derived from those of the mimetic triangle, where numbers are irrelevant. . . . The rhetoric of mastery retains the fund

Government urged to take action on national plan Posted: Mar 12, 2012 11:02 AM ET It is unacceptable that some cancer patients can't readily get the drugs they need because of supply problems, the Canadian Cancer Society says. The society is hearing from worried patients and doctors across the country, said Dan Demers, the group's director of public issues.

Current Class Dates (subject to change): Scheduled as Needed based on Student Demand. Email us atonlinetrain@nortonaudits.com if you are interested in this course. Description - This is an advanced-level class that takes an in-depth examination of severe noncompliance, clinical data fabrication and falsification, scientific misconduct and fraud cases. The course focus is on developing skills for preventing fraud and misconduct and preparing clinical research professionals to better handle severe noncompliance. Class Agenda/Modules - Instructors Make a Difference Defining Clinical Research Fraud and Misconduct Evaluation of Case History R.E.S.E.A.R.C.H. TM Skills Program Advanced Auditing and Monitoring Skills for Prevention Case Development Typical Class Attendee - Sponsor Auditors Contract Research Organization Auditors Clinical Research Associates and Monitors Institutional Review Board Internal Auditors Food and Drug Administration Investigators Independent Consultant Auditors Compliance Auditors Experience Level - Advanced; CRC, CRA or Auditor position for two years, preferably with a four year medical or science degree Class Price - $1500 (10% Southeast Regional Discount and 10% multiple persons from the same organization discounts are available)

SLIDEBOOM - Norton Scientific - 16April 2012- Current Class Dates (subject to change): Scheduled as Needed based on Student Demand. Email us atonlinetrain@nortonaudits.com if you are interested in this course. Description - This is an advanced-level class that takes an in-depth examination of severe noncompliance,clinical data fabrication and falsification, scientific misconduct and fraud cases. The course focus is on developing skills for preventing fraud and misconduct and preparing clinical research professionals to better handle severe noncompliance. Class Agenda/Modules - Instructors Make a Difference Defining Clinical Research Fraud and Misconduct Evaluation of Case History R.E.S.E.A.R.C.H. TM Skills Program Advanced Auditing and Monitoring Skills for Prevention Case Development Typical Class Attendee - Sponsor Auditors Contract Research Organization Auditors Clinical Research Associates and Monitors Institutional Review Board Internal Auditors Food and Drug Administration Investigators Independent Consultant Auditors Compliance Auditors Experience Level - Advanced; CRC, CRA or Auditor position for two years, preferably with a four year medical or science degree Class Price - $1500 (10% Southeast Regional Discount and 10% multiple persons from the same organization discounts are available)….view full story

Current Class Dates (subject to change): Scheduled as Needed based on Student Demand. Email us atonlinetrain@nortonaudits.com if you are interested in this course. Description - This is an advanced-level class that takes an in-depth examination of severe noncompliance, clinical data fabrication and falsification, scientific misconduct and fraud cases. The course focus is on developing skills for preventing fraud and misconduct and preparing clinical research professionals to better handle severe noncompliance. Class Agenda/Modules - Instructors Make a Difference Defining Clinical Research Fraud and Misconduct Evaluation of Case History R.E.S.E.A.R.C.H. TM Skills Program Advanced Auditing and Monitoring Skills for Prevention Case Development Typical Class Attendee - Sponsor Auditors Contract Research Organization Auditors Clinical Research Associates and Monitors Institutional Review Board Internal Auditors Food and Drug Administration Investigators Independent Consultant Auditors Compliance Auditors Experience Level - Advanced; CRC, CRA or Auditor position for two years, preferably with a four year medical or science degree Class Price - $1500 (10% Southeast Regional Discount and 10% multiple persons from the same organization discounts are available)

Norton Scientific today announced that the company has signed a deal with Advanced Scientific Technologies (AST), an independent sales rep company in Columbia, Maryland, to sell and support the Norton product line. "Tom Hill, the President of AST, is very excited about bringing the PAM and AstraGene products to the mid-Atlantic region of the United States," states Bryan Webb, President, Norton Scientific. The deal covers the District of Columbia, Delaware, Maryland, Virginia, South/Central Pennsylvania (including Pittsburgh) and South Jersey (south of Toms River). AST has a synergistic line of products including: Permeability & Solubility, pKa & log P, Dissolution, Microarrays, Scanner and Oligosynthesizer, 96/384 Plate-to-Plate transfers, Thermocyclers, Microfuges, Thermoshaker, Hybridization Oven, Electrophoresis and Electroblotting Systems, Power Supplies and Pipettes. Based in the Niagara Region of Canada, Norton was established in 2010 to take the knowledge and experience of the founders dating back 20+ years in the analysis of complex macromolecular & nano-particulate materials and design innovative measurement tools for use by bench scientists working in modern research facilities. Initial target markets for Norton are the important biochemical applications of protein aggregate screening and the kinetics of protein-protein interactions. Future developments will broaden this base to include applications in biopharmaceutical research, drug delivery, wound healing, advanced materials, food safety, brewing and viticulture, bio-materials and in-water pollution monitoring.

Norton Scientific today announced that the company has signed a deal with Advanced Scientific Technologies (AST), an independent sales rep company in Columbia, Maryland, to sell and support the Norton product line. "Tom Hill, the President of AST, is very excited about bringing the PAM and AstraGene products to the mid-Atlantic region of the United States," states Bryan Webb, President, Norton Scientific. The deal covers the District of Columbia, Delaware, Maryland, Virginia, South/Central Pennsylvania (including Pittsburgh) and South Jersey (south of Toms River). AST has a synergistic line of products including: Permeability & Solubility, pKa & log P, Dissolution, Microarrays, Scanner and Oligosynthesizer, 96/384 Plate-to-Plate transfers, Thermocyclers, Microfuges, Thermoshaker, Hybridization Oven, Electrophoresis and Electroblotting Systems, Power Supplies and Pipettes. Based in the Niagara Region of Canada, Norton was established in 2010 to take the knowledge and experience of the founders dating back 20+ years in the analysis of complex macromolecular & nano-particulate materials and design innovative measurement tools for use by bench scientists working in modern research facilities. Initial target markets for Norton are the important biochemical applications of protein aggregate screening and the kinetics of protein-protein interactions. Future developments will broaden this base to include applications in biopharmaceutical research, drug delivery, wound healing, advanced materials, food safety, brewing and viticulture, bio-materials and in-water pollution monitoring.